Osteopontin inhibits autophagy via CD44 and avβ3 integrin and promotes cell proliferation in osteoarthritic fibroblast-like synoviocytes
- PMID: 40102843
- PMCID: PMC11916941
- DOI: 10.1186/s12891-025-08509-y
Osteopontin inhibits autophagy via CD44 and avβ3 integrin and promotes cell proliferation in osteoarthritic fibroblast-like synoviocytes
Abstract
Objective: Osteoarthritis (OA) is closely related to aging, and autophagy is implicated in the retardation of aging. Activated synoviocytes play important roles in OA; the synoviocytes could produce osteopontin (OPN) and its main receptors CD44 and integrin, which are all involved in OA. The purpose of this study is to investigate whether OPN has an effect on autophagy in osteoarthritic synoviocytes.
Methods: We cultured human OA fibroblast-like synoviocytes (FLS) and treated them with rhOPN and antibodies against CD44 and CD51/61 (αvβ3 integrin) or isotype IgG to block the interaction between receptors and ligands. Infection with lentivirus mRFP-GFP-LC3, laser confocal imaging and Western blotting were used to determine changes in the expression of autophagy markers, and cell proliferation of FLS was assessed with a CCK-8 assay.
Results: Our results showed the expression level of autophagy marker protein LC3 II and the mRFP-GFP-LC3 puncta were significantly decreased after treatment with rhOPN when compared with the control group, when the FLS were incubated with antibodies against CD44 or CD51/61 (αvβ3 integrin) or with control isotype IgG for 1 h, followed by rhOPN treatment for 48 h, rhOPN could suppress the relative expression of LC3 II and Beclin1 via integrin and CD44 in the FLS, CCK-8 assay also showed that rhOPN significantly increased the cell proliferation and viability of FLS.
Conclusions: OPN could inhibit autophagy via CD44 and αvβ3 integrin and promote the proliferation of FLS, playing an important role in OA synovitis.
Keywords: Autophagy; CD44; Integrin; Osteoarthritis; Osteopontin; Synoviocyte.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate and publication: The studies that involved human participants were meticulously reviewed and granted approval by the Institutional Review Board of Xiangya Hospital, Central South University. All patients/participants provided their written informed consent prior to their involvement in this study. Data Sharing Statement: All data generated or analyzed during this study are included in the manuscript. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Mahmoudian A, Lohmander LS, Mobasheri A, Englund M, Luyten FP. Early-stage symptomatic osteoarthritis of the knee — time for action. Nat Rev Rheumatol. 2021;17(10):621–32. - PubMed
-
- Zhang F-J, Gao S-G, Cheng L, Tian J, Xu W-S, Luo W, Song Y, Yang Y, Lei G-H. The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee. Rheumatol Int. 2012;33(1):79–83. - PubMed
-
- O’Neill TW, McCabe PS, McBeth J. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis. Best Pract Res Clin Rheumatol. 2018;32(2):312–26. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
